Annual Current Assets
$447.74 M
-$68.76 M-13.31%
31 December 2023
Summary:
BioCryst Pharmaceuticals annual total current assets is currently $447.74 million, with the most recent change of -$68.76 million (-13.31%) on 31 December 2023. During the last 3 years, it has risen by +$123.94 million (+38.28%). BCRX annual current assets is now -20.91% below its all-time high of $566.14 million, reached on 31 December 2021.BCRX Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$424.12 M
+$60.66 M+16.69%
30 September 2024
Summary:
BioCryst Pharmaceuticals quarterly total current assets is currently $424.12 million, with the most recent change of +$60.66 million (+16.69%) on 30 September 2024. Over the past year, it has dropped by -$78.35 million (-15.59%). BCRX quarterly current assets is now -25.09% below its all-time high of $566.14 million, reached on 31 December 2021.BCRX Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCRX Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -13.3% | -15.6% |
| 3 y3 years | +38.3% | +67.8% |
| 5 y5 years | +291.6% | +438.2% |
BCRX Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -20.9% | +38.3% | -25.1% | +67.8% |
| 5 y | 5 years | -20.9% | +291.6% | -25.1% | +438.2% |
| alltime | all time | -20.9% | +3933.7% | -25.1% | +5136.0% |
BioCryst Pharmaceuticals Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $424.12 M(+16.7%) |
| June 2024 | - | $363.46 M(-18.7%) |
| Mar 2024 | - | $447.10 M(-9.9%) |
| Dec 2023 | $20.99 M(-37.3%) | $495.97 M(-1.3%) |
| Sept 2023 | - | $502.47 M(-1.7%) |
| June 2023 | - | $511.06 M(+4.1%) |
| Mar 2023 | - | $490.88 M(-5.0%) |
| Dec 2022 | $33.50 M(+52.2%) | $516.50 M(+1.5%) |
| Sept 2022 | - | $509.00 M(+2.9%) |
| June 2022 | - | $494.85 M(-3.3%) |
| Mar 2022 | - | $511.71 M(-9.6%) |
| Dec 2021 | $22.02 M(+101.7%) | $566.14 M(+124.0%) |
| Sept 2021 | - | $252.74 M(-4.9%) |
| June 2021 | - | $265.80 M(-2.9%) |
| Mar 2021 | - | $273.77 M(-15.5%) |
| Dec 2020 | $10.91 M(-0.2%) | $323.80 M(+99.3%) |
| Sept 2020 | - | $162.44 M(-20.3%) |
| June 2020 | - | $203.84 M(+62.4%) |
| Mar 2020 | - | $125.51 M(-23.6%) |
| Dec 2019 | $10.94 M(-66.3%) | $164.34 M(+108.6%) |
| Sept 2019 | - | $78.80 M(-24.0%) |
| June 2019 | - | $103.72 M(-11.8%) |
| Mar 2019 | - | $117.65 M(+2.9%) |
| Dec 2018 | $32.49 M(-38.5%) | $114.35 M(-11.0%) |
| Sept 2018 | - | $128.50 M(+38.7%) |
| June 2018 | - | $92.67 M(-11.0%) |
| Mar 2018 | - | $104.16 M(-16.9%) |
| Dec 2017 | $52.87 M(+131.3%) | $125.39 M(-28.5%) |
| Sept 2017 | - | $175.37 M(+90.1%) |
| June 2017 | - | $92.26 M(-18.7%) |
| Mar 2017 | - | $113.50 M(+69.4%) |
| Dec 2016 | $22.86 M(-61.0%) | $66.99 M(+3.6%) |
| Sept 2016 | - | $64.63 M(+40.2%) |
| June 2016 | - | $46.11 M(-8.6%) |
| Mar 2016 | - | $50.42 M(-21.0%) |
| Dec 2015 | $58.56 M(+23.2%) | $63.79 M(-24.5%) |
| Sept 2015 | - | $84.50 M(-21.1%) |
| June 2015 | - | $107.09 M(+31.6%) |
| Mar 2015 | - | $81.37 M(-8.9%) |
| Dec 2014 | $47.53 M(+604.7%) | $89.34 M(-33.9%) |
| Sept 2014 | - | $135.14 M(-2.2%) |
| June 2014 | - | $138.25 M(+286.9%) |
| Mar 2014 | - | $35.73 M(-15.2%) |
| Dec 2013 | $6.75 M(-56.4%) | $42.12 M(-10.1%) |
| Sept 2013 | - | $46.84 M(+39.7%) |
| June 2013 | - | $33.53 M(-5.3%) |
| Mar 2013 | - | $35.41 M(-15.7%) |
| Dec 2012 | $15.46 M(-47.3%) | $41.98 M(-9.9%) |
| Sept 2012 | - | $46.58 M(+3.4%) |
| June 2012 | - | $45.06 M(-14.9%) |
| Mar 2012 | - | $52.95 M(+0.2%) |
| Dec 2011 | $29.35 M(+33.2%) | $52.86 M(-12.6%) |
| Sept 2011 | - | $60.45 M(-24.3%) |
| June 2011 | - | $79.88 M(-20.5%) |
| Mar 2011 | - | $100.45 M(+14.9%) |
| Dec 2010 | $22.03 M(-29.3%) | $87.42 M(-2.6%) |
| Sept 2010 | - | $89.76 M(+12.5%) |
| June 2010 | - | $79.75 M(-14.0%) |
| Mar 2010 | - | $92.79 M(-16.4%) |
| Dec 2009 | $31.17 M | $111.02 M(+119.0%) |
| Sept 2009 | - | $50.69 M(-11.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2009 | - | $57.45 M(-11.8%) |
| Mar 2009 | - | $65.13 M(-13.2%) |
| Dec 2008 | $9.67 M(-81.0%) | $75.02 M(-6.3%) |
| Sept 2008 | - | $80.11 M(+44.0%) |
| June 2008 | - | $55.62 M(-28.0%) |
| Mar 2008 | - | $77.26 M(-15.8%) |
| Dec 2007 | $51.01 M(+124.8%) | $91.70 M(+0.2%) |
| Sept 2007 | - | $91.56 M(+78.0%) |
| June 2007 | - | $51.43 M(+8.8%) |
| Mar 2007 | - | $47.29 M(+3.3%) |
| Dec 2006 | $22.70 M(+25.1%) | $45.79 M(-5.9%) |
| Sept 2006 | - | $48.66 M(-20.6%) |
| June 2006 | - | $61.25 M(-14.7%) |
| Mar 2006 | - | $71.79 M(-11.5%) |
| Dec 2005 | $18.15 M(+111.1%) | $81.10 M(+157.6%) |
| Sept 2005 | - | $31.48 M(-6.8%) |
| June 2005 | - | $33.79 M(-19.0%) |
| Mar 2005 | - | $41.71 M(+74.7%) |
| Dec 2004 | $8.60 M(-8.5%) | $23.87 M(+1.5%) |
| Sept 2004 | - | $23.52 M(-4.8%) |
| June 2004 | - | $24.70 M(-15.1%) |
| Mar 2004 | - | $29.09 M(+40.5%) |
| Dec 2003 | $9.39 M(-42.6%) | $20.70 M(+2.6%) |
| Sept 2003 | - | $20.17 M(-22.6%) |
| June 2003 | - | $26.08 M(+10.7%) |
| Mar 2003 | - | $23.56 M(-5.5%) |
| Dec 2002 | $16.37 M(-38.7%) | $24.93 M(-10.6%) |
| Sept 2002 | - | $27.88 M(+0.5%) |
| June 2002 | - | $27.73 M(-7.5%) |
| Mar 2002 | - | $29.98 M(-7.5%) |
| Dec 2001 | $26.69 M(-40.8%) | $32.40 M(+2.5%) |
| Sept 2001 | - | $31.63 M(-4.5%) |
| June 2001 | - | $33.10 M(-2.9%) |
| Mar 2001 | - | $34.08 M(+32.3%) |
| Dec 2000 | $45.07 M(-7.7%) | $25.76 M(-2.6%) |
| Sept 2000 | - | $26.45 M(-2.6%) |
| June 2000 | - | $27.15 M(-0.9%) |
| Mar 2000 | - | $27.40 M(+11.4%) |
| Dec 1999 | $48.80 M(+687.1%) | $24.60 M(+23.0%) |
| Sept 1999 | - | $20.00 M(+9.9%) |
| June 1999 | - | $18.20 M(-6.2%) |
| Mar 1999 | - | $19.40 M(-15.3%) |
| Dec 1998 | $6.20 M(-8.8%) | $22.90 M(0.0%) |
| Sept 1998 | - | $22.90 M(+16.8%) |
| June 1998 | - | $19.60 M(-4.4%) |
| Mar 1998 | - | $20.50 M(+4.1%) |
| Dec 1997 | $6.80 M(-24.4%) | $19.70 M(-21.5%) |
| Sept 1997 | - | $25.10 M(-11.0%) |
| June 1997 | - | $28.20 M(+20.0%) |
| Mar 1997 | - | $23.50 M(-16.4%) |
| Dec 1996 | $9.00 M(+542.9%) | $28.10 M(-17.8%) |
| Sept 1996 | - | $34.20 M(+85.9%) |
| June 1996 | - | $18.40 M(+3.4%) |
| Mar 1996 | - | $17.80 M(+52.1%) |
| Dec 1995 | $1.40 M(-17.6%) | $11.70 M(-12.7%) |
| Sept 1995 | - | $13.40 M(-13.0%) |
| June 1995 | - | $15.40 M(+90.1%) |
| Mar 1995 | - | $8.10 M(-27.0%) |
| Dec 1994 | $1.70 M | $11.10 M(-14.6%) |
| Sept 1994 | - | $13.00 M(-1.5%) |
| June 1994 | - | $13.20 M(+3.9%) |
| Mar 1994 | - | $12.70 M |
FAQ
- What is BioCryst Pharmaceuticals annual total current assets?
- What is the all time high annual current assets for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals annual current assets year-on-year change?
- What is BioCryst Pharmaceuticals quarterly total current assets?
- What is the all time high quarterly current assets for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals quarterly current assets year-on-year change?
What is BioCryst Pharmaceuticals annual total current assets?
The current annual current assets of BCRX is $447.74 M
What is the all time high annual current assets for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high annual total current assets is $566.14 M
What is BioCryst Pharmaceuticals annual current assets year-on-year change?
Over the past year, BCRX annual total current assets has changed by -$68.76 M (-13.31%)
What is BioCryst Pharmaceuticals quarterly total current assets?
The current quarterly current assets of BCRX is $424.12 M
What is the all time high quarterly current assets for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high quarterly total current assets is $566.14 M
What is BioCryst Pharmaceuticals quarterly current assets year-on-year change?
Over the past year, BCRX quarterly total current assets has changed by -$78.35 M (-15.59%)